title: [Characteristics of the therapy of patients with type II diabetes mellitus and metabolic syndrome].
abstract: The article focuses on the action of sugar-lowering drugs of different groups (metformin, acarbose, gliquidone, diacamf, food fibre, in patients with type II diabetes mellitus presenting with the metabolic syndrome. All studied medicinal agents compensated the carbohydrate and lipid metabolism, lowered the body mass, delayed the development of atherosclerosis, which facts were found to alleviate the manifestations of the metabolic syndrome.
authors.forename: P M
authors.initials: PM
authors.lastname: Bodnar
authors.forename: L O
authors.initials: LO
authors.lastname: Kononenko
mesh_terms: D001835:Body Weight / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007333:Insulin Resistance; D050356:Lipid Metabolism / Q000187:drug effects; D024821:Metabolic Syndrome / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D007004:Hypoglycemic Agents